Get the Stockscreener App
0.161
21.65%
-0.0445
After Hours:
.16
-0.001
-0.62%
Universe Pharmaceuticals Inc stock is traded at $0.161, with a volume of 4.63M.
It is down -21.65% in the last 24 hours and down -75.21% over the past month.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
See More
Previous Close:
$0.2055
Open:
$0.1766
24h Volume:
4.63M
Relative Volume:
1.73
Market Cap:
$1.39M
Revenue:
$32.31M
Net Income/Loss:
$-6.16M
P/E Ratio:
-0.0947
EPS:
-1.7
Net Cash Flow:
$1.08M
1W Performance:
-61.67%
1M Performance:
-75.21%
6M Performance:
-99.71%
1Y Performance:
-99.35%
1-Day Range:
$0.142
$0.1766
1-Week Range:
$0.142
$0.445
52-Week Range:
$0.142
$64.80
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
0.161 | 1.39M | 32.31M | -6.16M | 1.08M | -1.70 |
|
ZTS
Zoetis Inc
|
174.12 | 78.56B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.61 | 43.15B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.51 | 43.00B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.29 | 19.59B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
150.51 | 15.24B | 2.24B | 385.90M | 440.10M | 3.73 |
Universe Pharmaceuticals Inc Stock (UPC) Latest News
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Gold Moves Higher; Estée Lauder Shares Slide - Benzinga
Will Universe Pharmaceuticals INC (UPC) meet earnings estimates this quarter? - US Post News
Volcon, Inc. and GlucoTrack, Inc. See Massive Gains, While Omega Therapeutics and Universe Pharmaceuticals Struggle – market - HPBL
Universe Pharmaceuticals faces Nasdaq delisting By Investing.com - Investing.com Australia
Stock market today: Captivision surged by 113.56% whereas Volcon jumped by 88.61% in early trading - Business Upturn
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Benzinga
Universe Pharmaceuticals faces Nasdaq delisting - Investing.com India
Universe Pharmaceuticals Faces Nasdaq Delisting Over Share Price Drop - TipRanks
NXP Semiconductors Reports Fourth Quarter and Full-Year 2024 Results - The Manila Times
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request - GlobeNewswire
UPCUniverse Pharmaceuticals Inc. Ordinary Shares Latest Stock News & Market Updates - StockTitan
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - EIN News
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Universe Pharmaceuticals announces shareholder meeting - MSN
Universe Pharmaceuticals stock hits 52-week low at $0.48 amid steep decline - MSN
Universe Pharmaceuticals Announces Extraordinary General Meeting for Share Consolidation - TipRanks
Universe Pharmaceuticals announces shareholder meeting By Investing.com - Investing.com UK
Vanda Pharmaceuticals (NASDAQ:VNDA) Now Covered by StockNews.com - Defense World
Universe Pharmaceuticals (NYSE:UPC) Trading Down 0.2% – Here’s Why - Defense World
Enterprise Bancorp (NASDAQ:EBTC) Coverage Initiated at StockNews.com - Defense World
MarketAxess Holdings Inc. Elects Roberto Hoornweg to Board of DirectorsNew York, January 27, 2025 – MarketAxess Holdings Inc. (Nasdaq: MKTX), a prominent operator of an electronic trading platform specializing in fixed-income securities, has announce - Defense World
Runway Growth Finance Corp. Holds Special Meeting and Reports Voting Results - Defense World
Universe Pharmaceuticals stock hits 52-week low at $0.6 amid steep decline - Investing.com Australia
Universe Pharmaceuticals stock hits 52-week low at $0.6 amid steep decline By Investing.com - Investing.com South Africa
Titan Pharma (NASDAQ:TTNP) Stock Quotes, Forecast and News Summary - Benzinga
Universe Pharmaceuticals (NYSE:UPC) Trading Down 0.4% – Here’s Why - Defense World
SABBY MANAGEMENT, LLC Acquires Significant Stake in Universe Pha - GuruFocus.com
Data-Based Insights About Universe Pharmaceuticals INC (UPC) - Stocks Register
Planet Labs PBC (PL) Outlook: Looking Back For Insights - Stocks Register
Universe Pharmaceuticals stock hits 52-week low at $0.61 - Investing.com
Universe Pharmaceuticals INC’s $15 Million Registered Direct Offering - Global Legal Chronicle
Universe Pharmaceuticals stock hits 52-week low at $0.68 - Investing.com
Universe Pharmaceuticals Files Registration for 37.5 Million Shares - TipRanks
Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring - The Manila Times
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) - The Manila Times
Univest Securities, LLC Announces Closing of $15 Million - GlobeNewswire
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe - EIN News
Universe Pharmaceuticals stock slides on capital raise of about $15M via securities offering - MSN
Universe Pharmaceuticals secures $15 million in share sale By Investing.com - Investing.com South Africa
Crude Oil Gains 2%; BioAge Labs Shares Plunge - Inkl
Universe Pharmaceuticals to sell 18.75M shares at 80c in direct offering - TipRanks
Nasdaq Down Over 100 Points; US Wholesale Inventories Rise By 0.2% - Inkl
Why Universe Pharmaceuticals (UPC) Stock Is Down 58% - Benzinga
CytoSorbents Announces Rights Offering - The Manila Times
Universe Pharmaceuticals secures $15 million in share sale - Investing.com
Universe Pharmaceuticals Inc Stock (UPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):